Annie McGuire
Personalreferent bei VERACYTE, INC.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Annie McGuire
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERACYTE, INC. | Personalreferent | - | - |
| General Counsel | 28.02.2022 | - |
Karriereverlauf von Annie McGuire
Ehemalige bekannte Positionen von Annie McGuire
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | General Counsel | - | - |
| Unternehmenssekretär | - | - |
Ausbildung von Annie McGuire
| New York Law School | Graduate Degree |
| Pace University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERACYTE, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Annie McGuire
- Erfahrung
